Condition
Smiling
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
20%
1 of 5 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (1)
P 2 (1)
P 4 (1)
Trial Status
Completed5
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06554379CompletedPrimary
The Effect of Periodontal Health on Smile
NCT05127018Phase 1CompletedPrimary
Higher Doses of Botulinum Toxin in the Treatment of Gummy Smile
NCT04527744Not ApplicableCompletedPrimary
Application of Botulinum Toxin at the Yonsei Point for the Treatment of Gummy Smile
NCT04820543Phase 4CompletedPrimary
Effects of Dose and Injection Site for Gummy Smile Treatment With Botulinum Type A
NCT03812965Phase 2CompletedPrimary
Botulinum Toxin in the Treatment of Gingival Smile
Showing all 5 trials